Up | AC
Home Page
Food and
Drug Administration
Endocrinologic and
Metabolic Drugs Advisory Committee
July 1-2, 2008
FDA
Disclaimer
Portions of this document have been determined to be exempt
from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §
552).
FDA Briefing Material (pdf)